Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Atsushi, Fukatsu"'
Autor:
Akari Inada, Atsushi Fukatsu
Publikováno v:
American Journal of Physiology: Renal Physiology; Nov2023, Vol. 325 Issue 5, pF527-F535, 9p
Autor:
Yohei Kozaki, Takatoshi Morinaga, Atsushi Fukatsu, Takeshi Ito, Takuji Ishimoto, Tomoki Kosugi, Daijo Inaguma, Hirofumi Tamai, Shoichi Maruyama
Publikováno v:
Clinical and Experimental Nephrology. 26:466-475
A Dialysis Outcomes and Practice Patterns Study (DOPPS) has shown a one-to-one male-to-female mortality ratio, notwithstanding the statistically longer life expectancy of women in the general population. This finding contrasts with the recent report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b49f9ff3501f34e10b2a9ca82f5acb
https://doi.org/10.1007/s10157-021-02168-8
https://doi.org/10.1007/s10157-021-02168-8
Publikováno v:
The American journal of pathology. 192(7)
Diabetic nephropathy (DN), once manifested, is unlikely to completely recover. Factors that influence DN progression were explored by investigating the process of glomerulosclerosis and interstitial fibrosis and chronological changes in glucose, albu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e19d321b29fe9457b2ab2519cc8475
https://pubmed.ncbi.nlm.nih.gov/35460614
https://pubmed.ncbi.nlm.nih.gov/35460614
Autor:
Shunsaku Nakagawa, Kumiko Nishihara, Hitomi Miyata, Haruka Shinke, Eri Tomita, Moto Kajiwara, Takeshi Matsubara, Noriyuki Iehara, Yoshinobu Igarashi, Hiroshi Yamada, Atsushi Fukatsu, Motoko Yanagita, Kazuo Matsubara, Satohiro Masuda
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136994 (2015)
In chronic kidney disease (CKD), progressive nephron loss causes glomerular sclerosis, as well as tubulointerstitial fibrosis and progressive tubular injury. In this study, we aimed to identify molecular changes that reflected the histopathological p
Externí odkaz:
https://doaj.org/article/d99b00b202314192b2c6e2710838127f
Autor:
Miho Tagawa, Takayuki Hamano, Hiroshi Nishi, Kenji Tsuchida, Norio Hanafusa, Atsushi Fukatsu, Kunitoshi Iseki, Yoshiharu Tsubakihara
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114678 (2014)
BACKGROUND/AIMS:The associations between phosphate, calcium, and intact parathyroid hormone (PTH) levels and composite cardiovascular end points have been studied. This study examined the associations of these markers with myocardial infarction (MI)
Externí odkaz:
https://doaj.org/article/37365122fb1f433e86bb35eaf7d40b5b
Autor:
Sachiko Yamada, Jin Nakamura, Misako Asada, Masayuki Takase, Taiji Matsusaka, Taku Iguchi, Ryo Yamada, Mari Tanaka, Atsuko Y Higashi, Tomohiko Okuda, Nariaki Asada, Atsushi Fukatsu, Hiroshi Kawachi, Daniel Graf, Eri Muso, Toru Kita, Takeshi Kimura, Ira Pastan, Aris N Economides, Motoko Yanagita
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89135 (2014)
Podocyte injury is the first step in the progression of glomerulosclerosis. Previous studies have demonstrated the beneficial effect of bone morphogenetic protein 7 (Bmp7) in podocyte injury and the existence of native Bmp signaling in podocytes. Loc
Externí odkaz:
https://doaj.org/article/2cbb3391f30847d5a744d0fe8de15080
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Erythropoiesis stimulating agents (ESA) are essential for better quality of life and longer life expectancy in end-stage kidney disease patients (ESKD). Resistance to ESA leads to worse prognosis in hemodialysis and peritoneal dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8192b6b0bc5f801c304901a9e373913
https://doi.org/10.1093/ndt/gfaa142.p1373
https://doi.org/10.1093/ndt/gfaa142.p1373
Luseogliflozin is a novel sodium glucose cotransporter 2 inhibitor for type 2 diabetes mellitus (T2DM) treatment. An exploratory Phase II study was conducted to assess the efficacy and safety of several doses of luseogliflozin in Japanese T2DM patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3835d07531f550262c378c885b61b6
Autor:
Atsushi Fukatsu, Soichi Sakai, Yutaka Seino, Yoshishige Samukawa, Takashi Sasaki, Michito Ubukata
Luseogliflozin--a novel, orally bioavailable, 1-thio-D-glucitol derivative and a selective sodium glucose cotransporter 2 inhibitor--has shown efficacy and tolerability in previous phase 2 studies. This phase 3, randomized, double-blind, placebo-cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a6eb357aa9c675a02f9ba212b9e764
Autor:
Akira Mima, Hideharu Abe, Kojiro Nagai, Hidenori Arai, Takeshi Matsubara, Makoto Araki, Kazuo Torikoshi, Tatsuya Tominaga, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Toshio Doi
Publikováno v:
PLoS ONE, Vol 7, Iss 9 (2012)
Externí odkaz:
https://doaj.org/article/a6e8f25da0994470bc610785ee825c22